Efficacy of the monoclonal antibodies and their mechanism of transmission-blocking activitiesof Plasmodium yoelii in Anopheles stephensi.
Efficacy of the monoclonal antibodies and their mechanism of transmission-blocking activitiesof Plasmodium yoelii in Anopheles stephensi.
批准号:
07670279
负责人:
TORII Motomi
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
针对约氏疟原虫受精卵和卵母细胞的单克隆抗体(mAb)已被证明可以阻断疟原虫对蚊子的感染。我们研究了单克隆抗体的功效及其传输阻断作用机制。mAb 4对约氏按蚊受精卵/卵胞体28kd蛋白(Pys28)的传输阻断作用在斯氏按蚊中完全完成。此外,mAb 4对p.o yoelii受精卵/卵胞体22 kD蛋白(Pys22)的阻断作用强于mAb 10。单克隆抗体4抑制合子的形成,单克隆抗体10抑制合子在血餐后4-15h内向卵母细胞成熟。体外实验表明,28kd和22kd决定因子已经存在于配子细胞的细胞质中,早期受精卵(约为24kd)中存在28kd和22kd决定因子。培养后30min)在细胞质中表达28kd或22kd的Mr蛋白,并分别在培养后2-24h或4-24h在细胞质表面合成。Pys28的表面表达开始时间早于Pys22。mAb 4的Fab片段在小鼠中具有传递阻断活性。mAb 10的Fab片段没有可检测到的传输阻断作用,但F (ab')_2有。这些数据表明,mAb 4和mAb 10在补体和抗体依赖性细胞介导的细胞毒性中抑制卵囊发育,mAb 4可能阻止靶表面蛋白的功能。
英文摘要
The monoclonal antibodies (mAb) against Plasmodium yoelii zygote and ookinete have been shown to block infectivity of the parasites to mosquitoes. We have studied the efficacy of the mAbs and their mechanism of transmission-blocking activities. The transmission-blocking effect of mAb 4 against P.yoelii zygote/ookinete 28 kD protein (Pys28) was complete in Anopheles stephensi. Moreover, the blockade of mAb 4 was stronger than that of mAb 10 against P.yoelii zygote/ookinete 22 kD protein (Pys22). Monoclonal antibody 4 inhibited the zygote formation and mAb 10 suppressed the maturation of zygotes to ookinetes in mosquito midgut in 4-15h after blood meal. In vitro experiment showed that both 28 kD and 22 kD determinants were already present in the cytoplasm of gametocytes, and early zygotes (approx.30 min post-culture) expressed a protein of Mr 28 kD or 22 kD in their cytoplasm and synthesized on their surface for 2-24h or 4-24h post-culture respectively. The onset of surface expression of Pys28 was earlier than Pys22. Fab fragments of mAb 4 had transmission-blocking activity in mice. Fab fragments of mAb 10 did not have detectable transmission-blocking effect, although F (ab')_2 did. These data suggest that mAb 4 and mAb 10 cause suppression of oocyst development in the complement and antibody-dependent cell-mediated cytotoxicity, and that mAb 4 might prevent the function of the target surface protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of novel transmission blocking vaccine targeting microgamete surface antigen of Plasmodium falciparum
-
批准号:20H03480
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2020
-
负责人:TORII Motomi
-
依托单位:
Assessment of P. vivax transmission-blocking activity of novel vaccine candidate (PvGs24)
-
批准号:16H05816
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2016
-
负责人:TORII Motomi
-
依托单位:
Development of novel P. falciparum malaria transmission-blocking vaccine targeted against Pf75
-
批准号:15H04725
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.98万
-
财政年份:2015
-
负责人:TORII Motomi
-
依托单位:
Development of novel malaria transmission blocking vaccine
-
批准号:21406010
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2009
-
负责人:TORII Motomi
-
依托单位:
Screening of sporozoite receptor molecule(s) on hepatocytes
-
批准号:21390124
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2009
-
负责人:TORII Motomi
-
依托单位:
Identification of erythrocyte proteins interacting with RhopH complex of malaria parasites
-
批准号:19390120
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2007
-
负责人:TORII Motomi
-
依托单位:
Rosetting of infected erythrocyte and virulence of Vivax malaria
-
批准号:18406009
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.14万
-
财政年份:2006
-
负责人:TORII Motomi
-
依托单位:
Identification of the binding domain of Plasmodium falciparum erythrocyte binding protein.
-
批准号:16390126
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2004
-
负责人:TORII Motomi
-
依托单位:
Identification of the erythrocyte receptor for Plasmodium yoelii RhopH complex
-
批准号:16017272
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$9.6万
-
财政年份:2004
-
负责人:TORII Motomi
-
依托单位:
Analysis of the protein expression level of the erythrocyte binding proteins in Plasmodium falciparum field isolates.
-
批准号:15406015
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.58万
-
财政年份:2003
-
负责人:TORII Motomi
-
依托单位:
Structure and functional analysis of high molecule weight rhoptry protein complex, RhopH, of rodent malaria parasite.
-
批准号:14370084
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2002
-
负责人:TORII Motomi
-
依托单位:
Expression of erythrocyte binding protein in Plasmodium falciparum merozoites isolated from endemic area
-
批准号:13576007
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2001
-
负责人:TORII Motomi
-
依托单位:
Analyisis of the Plasmodial rhoptry protein function by gene targeting
-
批准号:12670232
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:TORII Motomi
-
依托单位:
Role of the rhoptry proteins of sporozoites during hepatocyte invasion by Plasmodium
-
批准号:09670262
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1997
-
负责人:TORII Motomi
-
依托单位:
PROTEINS LOCALIZED IN THE APICAL ORGANELLES IN OOKINETES OF THE MALARIA PARASITE.
-
批准号:05807020
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1993
-
负责人:TORII Motomi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
GC Malaria - 利用按蚊天然抗疟共生菌阻断疟疾传播
-
批准号:--
-
项目类别:--
-
资助金额:150万元
-
批准年份:2022
-
负责人:王四宝
-
依托单位:
户外杀蚊真菌农药研制(GC Malaria)
-
批准号:82261128004
-
项目类别:国际(地区)合作与交流项目
-
资助金额:150.00万元
-
批准年份:2022
-
负责人:彭国雄
-
依托单位:
GC Malaria:研发昆虫不育技术用于控制城市疟疾媒介斯氏按蚊
-
批准号:82261128006
-
项目类别:国际(地区)合作与交流项目
-
资助金额:130.00万元
-
批准年份:2022
-
负责人:张东京
-
依托单位:
GC Malaria:高效实时户外疟疾媒介蚊虫诱捕监测技术和装置的研发
-
批准号:82261128003
-
项目类别:国际(地区)合作与交流项目
-
资助金额:150.00万元
-
批准年份:2022
-
负责人:陈晓光
-
依托单位:
GC malaria:户外诱杀蚊虫的真菌杀虫剂及其释放装置的研发和应用研究
-
批准号:82261128002
-
项目类别:国际(地区)合作与交流项目
-
资助金额:150.00万元
-
批准年份:2022
-
负责人:方卫国
-
依托单位:
GC Malaria-基于中药源的媒介生物传染病防控技术及产品开发
-
批准号:82261128005
-
项目类别:国际(地区)合作与交流项目
-
资助金额:150.00万元
-
批准年份:2022
-
负责人:姜标
-
依托单位: